Citadel Advisors
NMTR

Citadel Advisors’s 9 Meters Biopharma NMTR Stock Holding History

Citadel Advisors’s Portfolio NMTR Stock Details NMTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-1,388
Closed -$933 – 15597
2023
Q2 		$933 Hold
1,388
– – ﹤0.01% 14018
2023
Q1 		$1.93K Sell
1,388
-151
-10% -$285 ﹤0.01% 14232
2022
Q4 		$1.94K Buy
1,539
+149
+11% +$340 ﹤0.01% 14396
2022
Q3 		$6K Buy
+1,390
New +$6.89K ﹤0.01% 12364
2022
Q2 		– Sell
-2,005
Closed -$18.9K – 14566
2022
Q1 		$24K Sell
2,005
-3,593
-64% -$49.1K ﹤0.01% 13202
2021
Q4 		$110K Sell
5,598
-3,822
-41% -$85.5K ﹤0.01% 12622
2021
Q3 		$245K Buy
9,420
+5,289
+128% +$125K ﹤0.01% 11525
2021
Q2 		$91K Sell
4,131
-6,957
-63% -$171K ﹤0.01% 12992
2021
Q1 		$259K Buy
+11,088
New +$341K ﹤0.01% 11169
2020
Q2 		– Sell
-2,553
Closed -$28.8K – 10706
2020
Q1 		$26K Buy
+2,553
New +$32K ﹤0.01% 9235
2019
Q2 		– Sell
-2,752
Closed -$106K – 10053
2019
Q1 		$106K Buy
+2,752
New +$119K ﹤0.01% 8535
2018
Q4 		– Sell
-512
Closed -$37.9K – 9953
2018
Q3 		$70K Buy
+512
New +$88K ﹤0.01% 8711
2018
Q1 		– Sell
-91
Closed -$11K – 8950
2017
Q4 		$11K Sell
91
-180
-66% -$23.1K ﹤0.01% 7887
2017
Q3 		$38K Buy
+271
New +$42.4K ﹤0.01% 7242
2017
Q2 		– Sell
-84
Closed -$20K – 8244
2017
Q1 		$20K Hold
84
– – ﹤0.01% 7245
2016
Q4 		$29K Buy
+84
New +$24.4K ﹤0.01% 6999

Other funds holding NMTR

SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
SIS
Strategic Investment Solutions Orland Park, Illinois $437M AUM 30.41% 1-Year Est. Return
RCM
Requisite Capital Management Dallas, Texas $537M AUM 12.29% 1-Year Est. Return
BCMLT
Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $567M AUM 16.01% 1-Year Est. Return
SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return
RFA
Register Financial Advisors Atlanta, Georgia $326M AUM 48.38% 1-Year Est. Return

Citadel Advisors's NMTR Position: Q3 2023 in Review

Citadel Advisors sold out of 9 Meters Biopharma (NMTR) in Q3 2023, closing a stake of 1,388 shares — an estimated $933 sold.

Citadel Advisors first reported a position in NMTR in Q4 2016 and held it in 16 quarters. The position peaked at $259K in Q1 2021. 6 funds tracked by Wall St. Rank hold NMTR as of Q3 2023.

  • Citadel Advisors reported no remaining 9 Meters Biopharma position as of Q3 2023 after selling out during the quarter.
  • Citadel Advisors sold 1,388 9 Meters Biopharma shares in Q3 2023, an estimated $933.
  • Citadel Advisors first reported a position in 9 Meters Biopharma in Q4 2016 and held it in 16 quarters.
  • Citadel Advisors's 9 Meters Biopharma position peaked at $259K in Q1 2021.
  • 6 funds tracked by Wall St. Rank held 9 Meters Biopharma as of Q3 2023.

Based on Citadel Advisors's 13F filing for Q3 2023, filed 14 Nov 2023.